• 1. Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 2. West China School of Medicine, Sichuan University, Chengdu, 610041, P.R.China;
KANG Deying, Email: deyingkang@126.com
Export PDF Favorites Scan Get Citation

CONSORT Group members update the CONSORT (Consolidated Standards of Reporting Trials) statement by collecting relevant literatures to improve the reporting quality of randomised controlled trials. Recently, they have outlined CONSORT-Equity reporting standards, an extension to the CONSORT statement, which had been developed to improve the reporting of intervention effects in randomised trials where health equity is relevant. It will be helpful to improve social health equity or reduce social health inequities. This paper aims to introduce CONSORT-Equity and interprets its usage by a series of randomised trials where health equity is relevant.

Citation: YANG Wenjie, WANG Dandan, HUANG Litao, WEN Shu, ZHANG Yulin, ZHANG Chi, HONG Qi, KANG Deying. Interpretation of CONSORT-Equity 2017 extension: a statement for better reporting of health equity in randomised trials. Chinese Journal of Evidence-Based Medicine, 2019, 19(2): 238-247. doi: 10.7507/1672-2531.201804061 Copy

  • Previous Article

    The development of evidence-based medicine covering view of scientism and humanism: indicating the future prospect of evidence-based traditional Chinese medicine
  • Next Article

    The application and challenge of GRADE in systematic reviews of animal studies